A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

Condition:   Langerhans Cell HistiocytosisIntervention:   Drug: GSK2110183Sponsors:   Octagon Research Solutions, Inc.;   Octagon Research Solutions, Inc.Active, not recruiting - verified March 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials